Plain-English translation of NCT04699838 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a treatment approach for people who have been newly diagnosed with extensive stage small cell lung cancer and have never received treatment before. You would first receive standard chemotherapy drugs ( or plus ), and then continue with two newer medications called and to keep the cancer from coming back. The goal is to see if this combination helps people live longer without their cancer getting worse.
Small cell lung cancer is an aggressive type of cancer that needs new treatment options. Researchers believe that combining standard chemotherapy with these two newer medications—which work on the immune system and cancer cell repair—might help patients stay healthy longer than chemotherapy alone.
You would receive four cycles of chemotherapy infusions combined with the first medication, given every 3 weeks. After that, you would continue with maintenance treatment consisting of one infusion every 4 weeks plus daily oral tablets (taken twice daily for 7 days each month). Throughout the trial, you would have regular blood tests and imaging scans to monitor how you're responding to treatment. The study team will track how long you stay healthy without your cancer progressing.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
United States